Newborn Screening by Tandem Mass Spectrometry: Gaining Experience
Major expansion of newborn screening for inherited met-abolic disorders is taking place across the US and around the world as newer analytical technology is applied. Historically, each disorder to be screened required a separate test with associated costs and requirement for a portion of the dri...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Universidad de Belgrano - Documentos CEEGMD - Centro para el estudio de enfermedades genéticas, metabólicas y discapacidades. Facultad de Ciencias Exactas
2014
|
| Materias: | |
| Acceso en línea: | http://repositorio.ub.edu.ar/handle/123456789/2873 |
| Aporte de: |
| Sumario: | Major expansion of newborn screening for inherited met-abolic disorders is taking place across the US and around
the world as newer analytical technology is applied.
Historically, each disorder to be screened required a
separate test with associated costs and requirement for a
portion of the dried-blood-spot specimen from a heel
stick. This limitation of the existing tests was partially
responsible for the limitation of mandated newborn
screening in the US to a small number of disorders
(usually three to seven, depending on the state). |
|---|